Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center - ADDENDUM

Affiliations

¹ Department of Pharmacy, Parkland Health, Dallas, Texas.
² Clinical and Administrative Sciences, Department of Pharmacy, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma.
³ Department of Pharmacy, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.
⁴ Department of Nursing, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.
⁵ Infectious Diseases Section, Department of Internal Medicine, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.

Published Erratum

Taylor M Epperson et al. Antimicrob Steward Healthc Epidemiol. 2023.

. 2023 Dec 18;3(1):e240.

doi: 10.1017/ash.2023.524. eCollection 2023.

¹ Department of Pharmacy, Parkland Health, Dallas, Texas.
² Clinical and Administrative Sciences, Department of Pharmacy, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma.
³ Department of Pharmacy, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.
⁴ Department of Nursing, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.
⁵ Infectious Diseases Section, Department of Internal Medicine, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.

No abstract available

Erratum for

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center.
Epperson TM, Bennett KK, Kupiec KK, Speigel K, Neely SB, Resman-Targoff BH, Kinney KK, White BP. Epperson TM, et al. Antimicrob Steward Healthc Epidemiol. 2023 Jan 17;3(1):e15. doi: 10.1017/ash.2022.374. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 36714295 Free PMC article.

1. Epperson TM, Bennett KK, Kupiec KK, et al. Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e15. doi: 10.1017/ash.2022.374 - DOI - PMC - PubMed